Bosh sahifaABL • ETR
add
Abbott Laboratories
Yopilish kursi
110,24 €
Kunlik diapazon
110,22 € - 111,18 €
Yillik diapazon
90,00 € - 114,14 €
Bozor kapitalizatsiyasi
198,16 mlrd USD
Oʻrtacha hajm
337,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NYSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 10,64 mlrd | 4,85% |
Joriy xarajat | 3,94 mlrd | 4,62% |
Sof foyda | 1,65 mlrd | 14,62% |
Sof foyda marjasi | 15,48 | 9,32% |
Har bir ulushga tushum | 1,21 | 6,14% |
EBITDA | 2,80 mlrd | 7,79% |
Amaldagi soliq stavkasi | 15,15% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 7,79 mlrd | 10,52% |
Jami aktivlari | 74,36 mlrd | 3,14% |
Jami passivlari | 34,33 mlrd | -0,20% |
Umumiy kapital | 40,03 mlrd | — |
Tarqatilgan aksiyalar | 1,73 mlrd | — |
Narxi/balansdagi bahosi | 4,81 | — |
Aktivlardan daromad | 6,76% | — |
Kapitaldan daromad | 9,11% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 1,65 mlrd | 14,62% |
Operatsiyalardan naqd pul | 2,70 mlrd | 44,11% |
Sarmoyadan naqd pul | -594,00 mln | 6,31% |
Moliyadan naqd pul | -1,58 mlrd | 32,65% |
Naqd pulning sof oʻzgarishi | 571,00 mln | 150,71% |
Boʻsh pul | 2,01 mlrd | 95,79% |
Haqida
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, in the United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. Wikipedia
Tashkil etilgan
1888
Sayt
Xodimlar soni
114 000
